| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue | 22 | 2026 | 299 | 6.560 |
Why?
|
| Adipocytes | 28 | 2026 | 273 | 5.280 |
Why?
|
| Endosomes | 18 | 2016 | 180 | 2.300 |
Why?
|
| Adipogenesis | 11 | 2026 | 81 | 1.990 |
Why?
|
| Obesity | 17 | 2026 | 1265 | 1.970 |
Why?
|
| Neovascularization, Physiologic | 7 | 2019 | 112 | 1.950 |
Why?
|
| Thermogenesis | 6 | 2022 | 127 | 1.870 |
Why?
|
| Stem Cells | 5 | 2026 | 275 | 1.440 |
Why?
|
| Insulin Resistance | 8 | 2021 | 412 | 1.360 |
Why?
|
| Endocytosis | 14 | 2016 | 153 | 1.340 |
Why?
|
| Vesicular Transport Proteins | 13 | 2018 | 118 | 1.240 |
Why?
|
| Animals | 63 | 2026 | 21295 | 1.170 |
Why?
|
| Energy Metabolism | 5 | 2026 | 394 | 1.150 |
Why?
|
| Mitochondria | 7 | 2011 | 400 | 1.130 |
Why?
|
| Signal Transduction | 19 | 2019 | 3147 | 1.110 |
Why?
|
| Cell Differentiation | 9 | 2026 | 1382 | 1.060 |
Why?
|
| Uncoupling Protein 1 | 3 | 2024 | 51 | 1.020 |
Why?
|
| Insulin | 13 | 2021 | 692 | 0.980 |
Why?
|
| Cell Membrane | 14 | 2012 | 507 | 0.950 |
Why?
|
| Mice | 34 | 2025 | 11083 | 0.950 |
Why?
|
| Phosphatidylinositol Phosphates | 10 | 2010 | 40 | 0.870 |
Why?
|
| Lipolysis | 2 | 2024 | 47 | 0.870 |
Why?
|
| Neovascularization, Pathologic | 3 | 2022 | 141 | 0.860 |
Why?
|
| Thiazolidinediones | 5 | 2012 | 50 | 0.860 |
Why?
|
| Lipase | 1 | 2024 | 52 | 0.840 |
Why?
|
| Cyclic AMP | 1 | 2024 | 144 | 0.830 |
Why?
|
| Adipocytes, Beige | 2 | 2024 | 15 | 0.830 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 7 | 1997 | 46 | 0.800 |
Why?
|
| Adiponectin | 3 | 2019 | 37 | 0.780 |
Why?
|
| Monoamine Oxidase | 1 | 2022 | 8 | 0.760 |
Why?
|
| Wnt Signaling Pathway | 1 | 2023 | 84 | 0.750 |
Why?
|
| Subcutaneous Fat | 4 | 2026 | 49 | 0.740 |
Why?
|
| Glucose | 6 | 2019 | 476 | 0.740 |
Why?
|
| Membrane Proteins | 10 | 2015 | 921 | 0.710 |
Why?
|
| Humans | 57 | 2026 | 64795 | 0.690 |
Why?
|
| Nucleic Acids | 1 | 2022 | 60 | 0.690 |
Why?
|
| Intra-Abdominal Fat | 2 | 2012 | 36 | 0.690 |
Why?
|
| Blood Glucose | 5 | 2020 | 494 | 0.680 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2020 | 8 | 0.670 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2020 | 729 | 0.670 |
Why?
|
| Clathrin | 5 | 2012 | 23 | 0.670 |
Why?
|
| Diabetes, Gestational | 2 | 2020 | 142 | 0.670 |
Why?
|
| Adipocytes, White | 5 | 2021 | 27 | 0.660 |
Why?
|
| Muscle Proteins | 6 | 2004 | 117 | 0.650 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2007 | 347 | 0.620 |
Why?
|
| Monosaccharide Transport Proteins | 7 | 2004 | 43 | 0.620 |
Why?
|
| Glucose Intolerance | 2 | 2021 | 90 | 0.610 |
Why?
|
| Transcriptome | 3 | 2019 | 400 | 0.610 |
Why?
|
| Phosphatidylinositol 3-Kinases | 13 | 2004 | 178 | 0.600 |
Why?
|
| Oxygen Consumption | 4 | 2020 | 213 | 0.600 |
Why?
|
| Capillaries | 4 | 2016 | 30 | 0.590 |
Why?
|
| Leptin | 1 | 2019 | 88 | 0.590 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2019 | 39 | 0.570 |
Why?
|
| Aging | 1 | 2024 | 763 | 0.560 |
Why?
|
| RNA, Messenger | 7 | 2024 | 1573 | 0.530 |
Why?
|
| Mitochondrial Proteins | 4 | 2016 | 108 | 0.510 |
Why?
|
| Adipocytes, Brown | 4 | 2021 | 46 | 0.500 |
Why?
|
| Hypoglycemic Agents | 4 | 2012 | 225 | 0.500 |
Why?
|
| COS Cells | 11 | 2016 | 180 | 0.500 |
Why?
|
| Adipose Tissue, White | 4 | 2022 | 92 | 0.490 |
Why?
|
| Transferrin | 8 | 2016 | 70 | 0.490 |
Why?
|
| Adipose Tissue, Brown | 3 | 2022 | 124 | 0.470 |
Why?
|
| Epidermal Growth Factor | 4 | 2016 | 50 | 0.460 |
Why?
|
| PPAR gamma | 5 | 2024 | 77 | 0.440 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2014 | 5 | 0.430 |
Why?
|
| Homeostasis | 3 | 2019 | 378 | 0.420 |
Why?
|
| rab5 GTP-Binding Proteins | 5 | 2010 | 22 | 0.420 |
Why?
|
| Cell Culture Techniques | 2 | 2021 | 195 | 0.420 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2015 | 214 | 0.410 |
Why?
|
| Receptors, Transferrin | 2 | 2012 | 33 | 0.380 |
Why?
|
| Cells, Cultured | 10 | 2026 | 2190 | 0.380 |
Why?
|
| Fatty Liver | 2 | 2021 | 110 | 0.380 |
Why?
|
| Angiopoietins | 2 | 2011 | 5 | 0.370 |
Why?
|
| Single-Cell Analysis | 2 | 2025 | 119 | 0.370 |
Why?
|
| Proteins | 6 | 2016 | 762 | 0.370 |
Why?
|
| Biological Transport | 10 | 2016 | 292 | 0.360 |
Why?
|
| 3T3-L1 Cells | 9 | 2010 | 90 | 0.360 |
Why?
|
| Adrenal Glands | 1 | 2012 | 34 | 0.360 |
Why?
|
| Cell Proliferation | 2 | 2026 | 1029 | 0.350 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 4 | 1996 | 6 | 0.350 |
Why?
|
| Adenosine Triphosphate | 2 | 2010 | 298 | 0.350 |
Why?
|
| Microscopy, Fluorescence | 10 | 2016 | 403 | 0.350 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2012 | 144 | 0.350 |
Why?
|
| Amino Acid Sequence | 13 | 2010 | 1593 | 0.340 |
Why?
|
| Molecular Sequence Data | 13 | 2010 | 1985 | 0.340 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 116 | 0.340 |
Why?
|
| Carrier Proteins | 5 | 2010 | 718 | 0.340 |
Why?
|
| 3T3 Cells | 6 | 2003 | 111 | 0.340 |
Why?
|
| Protein Transport | 6 | 2014 | 410 | 0.330 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 231 | 0.330 |
Why?
|
| Adenylate Kinase | 1 | 2010 | 18 | 0.330 |
Why?
|
| Plasma Cells | 1 | 2010 | 53 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 9 | 2019 | 3459 | 0.320 |
Why?
|
| Hypoxia | 1 | 2011 | 120 | 0.320 |
Why?
|
| RNA, Long Noncoding | 2 | 2024 | 171 | 0.310 |
Why?
|
| Unfolded Protein Response | 1 | 2010 | 60 | 0.310 |
Why?
|
| Cholesterol | 3 | 2016 | 260 | 0.310 |
Why?
|
| Glucose Transporter Type 4 | 8 | 2008 | 60 | 0.310 |
Why?
|
| DNA-Binding Proteins | 5 | 2016 | 1220 | 0.300 |
Why?
|
| Membrane Fusion | 4 | 2007 | 68 | 0.300 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 553 | 0.290 |
Why?
|
| Oxygen | 3 | 2022 | 317 | 0.290 |
Why?
|
| Electron Transport | 1 | 2008 | 28 | 0.290 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2016 | 152 | 0.290 |
Why?
|
| Diet, High-Fat | 4 | 2021 | 180 | 0.280 |
Why?
|
| Phosphorylation | 8 | 2015 | 961 | 0.280 |
Why?
|
| Green Fluorescent Proteins | 8 | 2010 | 374 | 0.270 |
Why?
|
| Zinc Fingers | 5 | 2010 | 105 | 0.270 |
Why?
|
| Protein Structure, Tertiary | 7 | 2007 | 677 | 0.260 |
Why?
|
| Male | 19 | 2021 | 30811 | 0.250 |
Why?
|
| Tranexamic Acid | 1 | 2026 | 9 | 0.240 |
Why?
|
| Antifibrinolytic Agents | 1 | 2026 | 19 | 0.240 |
Why?
|
| Body Weight | 2 | 2022 | 373 | 0.240 |
Why?
|
| Proto-Oncogene Proteins | 3 | 1998 | 344 | 0.240 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2016 | 236 | 0.240 |
Why?
|
| RNA, Small Interfering | 6 | 2016 | 969 | 0.230 |
Why?
|
| Glucose Tolerance Test | 3 | 2016 | 98 | 0.230 |
Why?
|
| Lymphocytes | 2 | 1996 | 202 | 0.220 |
Why?
|
| Binding Sites | 8 | 2002 | 920 | 0.220 |
Why?
|
| Colforsin | 1 | 2024 | 25 | 0.220 |
Why?
|
| Acyltransferases | 1 | 2024 | 32 | 0.220 |
Why?
|
| Cytoskeleton | 4 | 2003 | 140 | 0.220 |
Why?
|
| Body Mass Index | 3 | 2022 | 885 | 0.210 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2024 | 51 | 0.210 |
Why?
|
| Evolution, Molecular | 1 | 2007 | 347 | 0.210 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 1996 | 229 | 0.210 |
Why?
|
| Interleukin-8 | 1 | 2024 | 94 | 0.210 |
Why?
|
| Time Factors | 8 | 2017 | 3744 | 0.200 |
Why?
|
| RNA Stability | 1 | 2024 | 104 | 0.200 |
Why?
|
| Longevity | 1 | 2024 | 117 | 0.200 |
Why?
|
| Calmodulin | 1 | 2003 | 23 | 0.200 |
Why?
|
| Thiazoles | 1 | 2003 | 45 | 0.190 |
Why?
|
| HeLa Cells | 5 | 2016 | 540 | 0.190 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2002 | 30 | 0.190 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 37 | 0.190 |
Why?
|
| Phosphatidylinositols | 2 | 1999 | 51 | 0.190 |
Why?
|
| Inflammation | 2 | 2024 | 1185 | 0.180 |
Why?
|
| Calcium-Binding Proteins | 1 | 2022 | 94 | 0.180 |
Why?
|
| Adipose Tissue, Beige | 1 | 2022 | 3 | 0.180 |
Why?
|
| Dietary Fats | 2 | 2014 | 178 | 0.180 |
Why?
|
| Neurogenesis | 1 | 2022 | 65 | 0.180 |
Why?
|
| Serine Endopeptidases | 1 | 2002 | 122 | 0.180 |
Why?
|
| Androstadienes | 3 | 1997 | 43 | 0.180 |
Why?
|
| Female | 12 | 2020 | 33770 | 0.180 |
Why?
|
| Body Height | 1 | 2022 | 66 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 1 | 2002 | 181 | 0.180 |
Why?
|
| Cell Separation | 1 | 2022 | 147 | 0.170 |
Why?
|
| Adult | 7 | 2022 | 17247 | 0.170 |
Why?
|
| Transfection | 6 | 2011 | 701 | 0.170 |
Why?
|
| Endothelial Cells | 2 | 2014 | 204 | 0.170 |
Why?
|
| beta-Cyclodextrins | 1 | 2000 | 21 | 0.160 |
Why?
|
| Adherens Junctions | 1 | 2000 | 13 | 0.160 |
Why?
|
| Trans-Activators | 1 | 2002 | 321 | 0.160 |
Why?
|
| Gene Expression Profiling | 3 | 2019 | 794 | 0.160 |
Why?
|
| Endothelium, Vascular | 2 | 2003 | 177 | 0.160 |
Why?
|
| Cytosol | 5 | 2003 | 183 | 0.160 |
Why?
|
| Protein Binding | 9 | 2011 | 1640 | 0.160 |
Why?
|
| Amino Acid Motifs | 3 | 2007 | 156 | 0.160 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2015 | 83 | 0.160 |
Why?
|
| Luminescent Proteins | 5 | 2003 | 130 | 0.160 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2010 | 364 | 0.150 |
Why?
|
| Phenotype | 3 | 2018 | 1236 | 0.150 |
Why?
|
| Lipid Metabolism | 2 | 2021 | 224 | 0.150 |
Why?
|
| In Vitro Techniques | 4 | 2014 | 494 | 0.150 |
Why?
|
| Point Mutation | 2 | 2014 | 168 | 0.150 |
Why?
|
| Heterografts | 1 | 2019 | 67 | 0.140 |
Why?
|
| Physical Conditioning, Animal | 1 | 2019 | 44 | 0.140 |
Why?
|
| Enzyme Inhibitors | 3 | 2004 | 364 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2004 | 498 | 0.140 |
Why?
|
| Mice, Nude | 1 | 2019 | 287 | 0.140 |
Why?
|
| Primary Myelofibrosis | 1 | 2018 | 11 | 0.140 |
Why?
|
| Aorta | 2 | 2018 | 109 | 0.140 |
Why?
|
| Recombinant Proteins | 4 | 2010 | 710 | 0.140 |
Why?
|
| Isoenzymes | 2 | 1995 | 129 | 0.140 |
Why?
|
| Mutation | 5 | 2010 | 2667 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 370 | 0.130 |
Why?
|
| Blotting, Western | 3 | 2010 | 610 | 0.130 |
Why?
|
| Pregnancy | 3 | 2020 | 2361 | 0.130 |
Why?
|
| Fatty Acids | 2 | 2012 | 196 | 0.130 |
Why?
|
| Tyrosine | 5 | 2003 | 93 | 0.130 |
Why?
|
| Cell Plasticity | 1 | 2017 | 24 | 0.130 |
Why?
|
| Cell Compartmentation | 2 | 1993 | 35 | 0.130 |
Why?
|
| Subcellular Fractions | 4 | 2003 | 68 | 0.130 |
Why?
|
| Mice, Obese | 2 | 2008 | 80 | 0.120 |
Why?
|
| src-Family Kinases | 1 | 1996 | 64 | 0.120 |
Why?
|
| Rats | 7 | 2012 | 1997 | 0.120 |
Why?
|
| Multienzyme Complexes | 1 | 1996 | 88 | 0.120 |
Why?
|
| Proprotein Convertase 1 | 1 | 2016 | 7 | 0.120 |
Why?
|
| Intracellular Membranes | 2 | 1993 | 47 | 0.120 |
Why?
|
| Enkephalins | 1 | 2016 | 20 | 0.120 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 18 | 0.120 |
Why?
|
| Interleukin-33 | 1 | 2016 | 19 | 0.120 |
Why?
|
| Iodide Peroxidase | 1 | 2016 | 23 | 0.120 |
Why?
|
| Cell Transplantation | 1 | 2016 | 41 | 0.120 |
Why?
|
| Glucose Clamp Technique | 1 | 2016 | 57 | 0.120 |
Why?
|
| Integrin beta1 | 1 | 2016 | 32 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2017 | 298 | 0.120 |
Why?
|
| Proto-Oncogenes | 1 | 1995 | 9 | 0.120 |
Why?
|
| Autografts | 1 | 2015 | 9 | 0.120 |
Why?
|
| Protein Precursors | 1 | 2016 | 85 | 0.120 |
Why?
|
| Ion Channels | 1 | 2016 | 92 | 0.110 |
Why?
|
| Deoxyglucose | 2 | 1994 | 32 | 0.110 |
Why?
|
| Adiposity | 2 | 2015 | 83 | 0.110 |
Why?
|
| Microscopy, Electron | 4 | 2017 | 253 | 0.110 |
Why?
|
| Receptors, Growth Factor | 1 | 2015 | 19 | 0.110 |
Why?
|
| Middle Aged | 5 | 2020 | 18122 | 0.110 |
Why?
|
| Cell Line | 5 | 2003 | 2036 | 0.110 |
Why?
|
| Models, Biological | 4 | 2012 | 1204 | 0.110 |
Why?
|
| Exocytosis | 4 | 2007 | 61 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 512 | 0.110 |
Why?
|
| Graft Survival | 1 | 2015 | 297 | 0.110 |
Why?
|
| Liposomes | 3 | 2003 | 116 | 0.110 |
Why?
|
| Leucine | 1 | 1994 | 67 | 0.100 |
Why?
|
| Microvessels | 1 | 2014 | 18 | 0.100 |
Why?
|
| Weight Gain | 1 | 2015 | 166 | 0.100 |
Why?
|
| Seizures | 1 | 2014 | 139 | 0.100 |
Why?
|
| Postpartum Period | 1 | 2015 | 189 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 146 | 0.090 |
Why?
|
| Cricetinae | 3 | 2002 | 369 | 0.090 |
Why?
|
| Protein Structure, Quaternary | 2 | 2003 | 102 | 0.090 |
Why?
|
| Cadherins | 2 | 2012 | 90 | 0.090 |
Why?
|
| Fasting | 1 | 2012 | 51 | 0.090 |
Why?
|
| Macrophages, Peritoneal | 1 | 2012 | 74 | 0.090 |
Why?
|
| Ethers, Cyclic | 1 | 1991 | 3 | 0.090 |
Why?
|
| Microcirculation | 1 | 2011 | 59 | 0.090 |
Why?
|
| Autoantigens | 2 | 2010 | 138 | 0.090 |
Why?
|
| Antigens, CD | 2 | 2012 | 346 | 0.090 |
Why?
|
| Hypoglycemia | 1 | 2012 | 64 | 0.080 |
Why?
|
| Mass Spectrometry | 2 | 2004 | 294 | 0.080 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2010 | 16 | 0.080 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2010 | 12 | 0.080 |
Why?
|
| Leukopenia | 1 | 2010 | 16 | 0.080 |
Why?
|
| Antigens, Viral | 1 | 2011 | 131 | 0.080 |
Why?
|
| Biopsy | 1 | 2012 | 454 | 0.080 |
Why?
|
| Viral Envelope Proteins | 1 | 2011 | 101 | 0.080 |
Why?
|
| Antibodies | 1 | 2011 | 187 | 0.080 |
Why?
|
| Gene Expression | 2 | 2016 | 856 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 383 | 0.080 |
Why?
|
| Hematopoiesis | 1 | 2010 | 126 | 0.080 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2010 | 54 | 0.080 |
Why?
|
| Gastric Bypass | 1 | 2011 | 69 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2011 | 189 | 0.080 |
Why?
|
| Coated Pits, Cell-Membrane | 3 | 1994 | 5 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2010 | 71 | 0.080 |
Why?
|
| Oxidative Phosphorylation | 1 | 2010 | 42 | 0.080 |
Why?
|
| Glucose Transporter Type 1 | 3 | 1994 | 51 | 0.080 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2010 | 80 | 0.080 |
Why?
|
| Macrophages | 1 | 2015 | 1047 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2010 | 202 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2015 | 1549 | 0.080 |
Why?
|
| RNA Splicing | 1 | 2010 | 164 | 0.080 |
Why?
|
| Golgi Apparatus | 3 | 1994 | 65 | 0.080 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 178 | 0.080 |
Why?
|
| Lipids | 1 | 2012 | 327 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2003 | 59 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 618 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2008 | 1 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 543 | 0.070 |
Why?
|
| High Mobility Group Proteins | 1 | 2008 | 27 | 0.070 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 53 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2012 | 2149 | 0.070 |
Why?
|
| Lipid Droplets | 2 | 2020 | 34 | 0.070 |
Why?
|
| Epididymis | 1 | 2008 | 26 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2017 | 244 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 426 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2004 | 152 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 1990 | 431 | 0.070 |
Why?
|
| Young Adult | 2 | 2020 | 4777 | 0.060 |
Why?
|
| Cytokines | 1 | 2011 | 952 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 850 | 0.060 |
Why?
|
| Triglycerides | 1 | 2008 | 247 | 0.060 |
Why?
|
| Plasmids | 2 | 2011 | 293 | 0.060 |
Why?
|
| Aged | 3 | 2020 | 14847 | 0.060 |
Why?
|
| Dimerization | 2 | 2003 | 145 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 2 | 1996 | 8 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 1216 | 0.060 |
Why?
|
| Perilipin-1 | 2 | 2020 | 11 | 0.060 |
Why?
|
| Atlases as Topic | 1 | 2025 | 13 | 0.060 |
Why?
|
| Models, Molecular | 3 | 2010 | 1158 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 2008 | 223 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2003 | 1007 | 0.060 |
Why?
|
| Palmitic Acid | 1 | 2004 | 14 | 0.060 |
Why?
|
| Chaperonin 60 | 1 | 2004 | 19 | 0.060 |
Why?
|
| RNA, Complementary | 1 | 2004 | 19 | 0.060 |
Why?
|
| Kinetics | 3 | 2007 | 758 | 0.050 |
Why?
|
| Annexin A2 | 2 | 2003 | 7 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2004 | 70 | 0.050 |
Why?
|
| Cyclodextrins | 2 | 2003 | 15 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 1996 | 355 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 440 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 1160 | 0.050 |
Why?
|
| Chromatography, Gel | 1 | 2003 | 63 | 0.050 |
Why?
|
| CHO Cells | 2 | 1994 | 191 | 0.050 |
Why?
|
| Lipid Bilayers | 1 | 2003 | 53 | 0.050 |
Why?
|
| Cattle | 2 | 2003 | 318 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2017 | 281 | 0.050 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2003 | 82 | 0.050 |
Why?
|
| Receptor, Insulin | 2 | 2004 | 52 | 0.050 |
Why?
|
| Proteome | 1 | 2004 | 151 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2003 | 94 | 0.050 |
Why?
|
| Insulin-Like Growth Factor II | 2 | 2015 | 23 | 0.050 |
Why?
|
| Myosins | 1 | 2004 | 117 | 0.050 |
Why?
|
| Dynamins | 1 | 2002 | 12 | 0.050 |
Why?
|
| Smad2 Protein | 1 | 2002 | 8 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2002 | 57 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 130 | 0.050 |
Why?
|
| Ligands | 1 | 2003 | 416 | 0.050 |
Why?
|
| Potassium | 1 | 2002 | 97 | 0.050 |
Why?
|
| Actins | 1 | 2003 | 262 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2003 | 131 | 0.050 |
Why?
|
| Inositol Phosphates | 1 | 2001 | 17 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2003 | 136 | 0.040 |
Why?
|
| Infant | 2 | 2018 | 1685 | 0.040 |
Why?
|
| Adult Stem Cells | 1 | 2021 | 30 | 0.040 |
Why?
|
| Adolescent | 1 | 2012 | 6293 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2001 | 82 | 0.040 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2021 | 14 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 1285 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1635 | 0.040 |
Why?
|
| Transport Vesicles | 1 | 2001 | 14 | 0.040 |
Why?
|
| Half-Life | 1 | 2001 | 81 | 0.040 |
Why?
|
| Caveolins | 1 | 2000 | 7 | 0.040 |
Why?
|
| Caveolin 1 | 1 | 2000 | 10 | 0.040 |
Why?
|
| Trypsin | 1 | 2000 | 43 | 0.040 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2021 | 42 | 0.040 |
Why?
|
| Precipitin Tests | 2 | 2003 | 78 | 0.040 |
Why?
|
| Amino Acids | 1 | 2001 | 148 | 0.040 |
Why?
|
| Cell Count | 1 | 2000 | 131 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 448 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 52 | 0.040 |
Why?
|
| Fluorescent Dyes | 2 | 2006 | 201 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2021 | 178 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2000 | 173 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2021 | 232 | 0.040 |
Why?
|
| Cysteine | 1 | 2000 | 107 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2003 | 17 | 0.040 |
Why?
|
| Calcium | 1 | 2003 | 583 | 0.040 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 193 | 0.040 |
Why?
|
| Cell Communication | 1 | 2020 | 134 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2006 | 706 | 0.040 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 1998 | 5 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 5575 | 0.040 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2018 | 1 | 0.040 |
Why?
|
| Consanguinity | 1 | 2018 | 6 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2021 | 270 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 130 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2018 | 123 | 0.030 |
Why?
|
| Syndrome | 1 | 2018 | 178 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 139 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2018 | 54 | 0.030 |
Why?
|
| Pedigree | 1 | 2018 | 198 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2001 | 269 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1998 | 151 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 333 | 0.030 |
Why?
|
| Cell Shape | 1 | 2017 | 12 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2017 | 21 | 0.030 |
Why?
|
| Gene Editing | 1 | 2021 | 328 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 2017 | 37 | 0.030 |
Why?
|
| Cellular Reprogramming | 1 | 2017 | 42 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2017 | 129 | 0.030 |
Why?
|
| Cyclophilins | 1 | 2016 | 12 | 0.030 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1996 | 8 | 0.030 |
Why?
|
| Child | 2 | 2018 | 4603 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 632 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 902 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 1998 | 430 | 0.030 |
Why?
|
| Isoquinolines | 1 | 1996 | 30 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 2018 | 176 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2016 | 278 | 0.030 |
Why?
|
| Lung | 1 | 2000 | 965 | 0.030 |
Why?
|
| Crystallography, X-Ray | 2 | 2010 | 419 | 0.030 |
Why?
|
| Class III Phosphatidylinositol 3-Kinases | 1 | 2015 | 5 | 0.030 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2015 | 10 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1995 | 203 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 351 | 0.030 |
Why?
|
| Beclin-1 | 1 | 2015 | 22 | 0.030 |
Why?
|
| Psychology | 1 | 2015 | 45 | 0.030 |
Why?
|
| Anthropometry | 1 | 2015 | 85 | 0.030 |
Why?
|
| Hydrolysis | 1 | 1995 | 147 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 66 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 179 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 211 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 80 | 0.030 |
Why?
|
| Gestational Age | 1 | 2015 | 195 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 116 | 0.030 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 1994 | 5 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 1994 | 25 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 1994 | 11 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 2270 | 0.030 |
Why?
|
| Down-Regulation | 1 | 1995 | 324 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1994 | 22 | 0.030 |
Why?
|
| Type C Phospholipases | 1 | 1994 | 34 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1994 | 251 | 0.030 |
Why?
|
| Adaptor Protein Complex gamma Subunits | 1 | 1993 | 1 | 0.030 |
Why?
|
| Adaptor Protein Complex alpha Subunits | 1 | 1993 | 3 | 0.030 |
Why?
|
| Nocodazole | 1 | 1993 | 15 | 0.030 |
Why?
|
| Hemagglutinins | 1 | 1993 | 17 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 1994 | 68 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1993 | 81 | 0.020 |
Why?
|
| Tubulin | 1 | 1993 | 73 | 0.020 |
Why?
|
| Epitopes | 1 | 1994 | 292 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 660 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1995 | 752 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 1993 | 389 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 796 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 1995 | 564 | 0.020 |
Why?
|
| Microtubules | 1 | 1993 | 211 | 0.020 |
Why?
|
| Galactosides | 1 | 2012 | 3 | 0.020 |
Why?
|
| Pericytes | 1 | 2012 | 16 | 0.020 |
Why?
|
| Research Design | 1 | 2015 | 583 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2011 | 13 | 0.020 |
Why?
|
| Methylglucosides | 1 | 1991 | 4 | 0.020 |
Why?
|
| Insulin Antagonists | 1 | 1991 | 3 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 1991 | 9 | 0.020 |
Why?
|
| Indoles | 1 | 2012 | 111 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1993 | 415 | 0.020 |
Why?
|
| 3-O-Methylglucose | 1 | 1991 | 16 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 1991 | 25 | 0.020 |
Why?
|
| rab4 GTP-Binding Proteins | 1 | 2010 | 3 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 624 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2010 | 32 | 0.020 |
Why?
|
| Mannosephosphates | 1 | 1990 | 2 | 0.020 |
Why?
|
| Receptor, IGF Type 2 | 1 | 1990 | 3 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 793 | 0.020 |
Why?
|
| Receptors, Somatomedin | 1 | 1990 | 10 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 1990 | 32 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 666 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 149 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 181 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 237 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 620 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 156 | 0.020 |
Why?
|
| Temperature | 1 | 1990 | 311 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 2679 | 0.020 |
Why?
|
| Biomarkers | 1 | 1993 | 1466 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 790 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 1558 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 5396 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 640 | 0.010 |
Why?
|
| Myosin Type I | 1 | 2004 | 7 | 0.010 |
Why?
|
| Chromones | 1 | 2004 | 18 | 0.010 |
Why?
|
| Molecular Motor Proteins | 1 | 2004 | 33 | 0.010 |
Why?
|
| Protein Array Analysis | 1 | 2004 | 26 | 0.010 |
Why?
|
| Cell Size | 1 | 2004 | 41 | 0.010 |
Why?
|
| Rhodamines | 1 | 2003 | 20 | 0.010 |
Why?
|
| Morpholines | 1 | 2004 | 90 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 2003 | 56 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2003 | 34 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 165 | 0.010 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2003 | 3 | 0.010 |
Why?
|
| Digitonin | 1 | 2003 | 4 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 292 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2003 | 21 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2003 | 138 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 53 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 268 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2003 | 215 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 176 | 0.010 |
Why?
|
| Proteomics | 1 | 2004 | 291 | 0.010 |
Why?
|
| United States | 1 | 2015 | 8036 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 448 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 580 | 0.010 |
Why?
|
| Phospholipids | 1 | 2001 | 81 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2001 | 301 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2003 | 419 | 0.010 |
Why?
|
| Apoptosis | 1 | 2003 | 1091 | 0.010 |
Why?
|